PANDEIA THERAPEUTICS LIMITED
PANDEIA THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 11463856, incorporated on 13 July 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 7 years. Registered office address: CB22 3FH Cambridge, the United Kingdom. Directors include THE CAMBRIDGE PARTNERSHIP LIMITED and JENNIFER RHODES. Sole shareholder is Acadia Pharmaceuticals Inc.. Associated with 20 related entities, including CASSINI BIO LIMITED, INTERACT BIO LTD, and VIMELA THERAPEUTICS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
THE CAMBRIDGE PARTNERSHIP THE DOROTHY HODGKIN BLDG BABRAHAM RESEARCH CAMPUS
BABRAHAM
CB22 3FH CAMBRIDGE
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11463856 | 2026-06-01 | open_in_new |